Literature DB >> 11260026

Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies.

M Inaoki1, M Kodera, A Fujimoto, H C Nousari, G J Anhalt, K Takehara.   

Abstract

Paraneoplastic pemphigus (PNP) is an autoimmune mucocutaneous blistering disease characterized by IgG autoantibodies that bind to various epithelia and immunoprecipitate a complex of 250, 230, 210, 190 and 170 kDa proteins. A recent study has suggested that PNP patients have antidesmoglein (Dsg) 3 autoantibody and that the antibody plays a pathogenic role in PNP. We report a 72-year-old woman with PNP associated with thymoma and adenocarcinoma of the lung. Diagnosis of PNP was made by the characteristic clinical, histological and immunopathological findings, as well as immunoprecipitation of characteristic 230, 210 and 190 kDa proteins. Using enzyme-linked immunosorbent assay with baculovirus-expressed recombinant proteins, the patient's serum was negative against both Dsg 3 and Dsg 1. This finding is unusual, and it suggests that the target antigen, which is involved in acantholysis, may be other than Dsg 3 in this case.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260026     DOI: 10.1046/j.1365-2133.2001.04095.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa.

Authors:  Jong Hoon Kim; Soo-Chan Kim
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

2.  Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome-From Pemphigus to Lichenoid Dermatitis.

Authors:  Farzan Solimani; Roberto Maglie; Robert Pollmann; Thomas Schmidt; Ansgar Schmidt; Norito Ishii; Björn Tackenberg; Andreas Kirschbaum; Dario Didona; Julia Pickert; Rüdiger Eming; Takashi Hashimoto; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

Review 3.  Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Authors:  Yen Loo Lim; Gerome Bohelay; Sho Hanakawa; Philippe Musette; Baptiste Janela
Journal:  Front Mol Biosci       Date:  2022-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.